IQ Biozoom is developing technology for non-invasive diagnostic tests that can be used at home. The technology makes it possible to measure the concentration of selected biomarkers in biological material in a non-invasive, real-time manner, with very high accuracy, e.g. it allows estimating the concentration of glucose or lactate in saliva.
This solution allows monitoring of therapeutically important biomarkers for disorders and diseases such as diabetes, pre-diabetic states, insulin resistance, metabolic disorders, Hashimoto's disease, endocrine disorders, infertility. Due to the possibility of using IQ Biozoom technology in a non-invasive manner, it will significantly increase the comfort of life of chronic patients who need to control some parameters very often, even several times a day. The technology can also be used to non-invasively monitor lactic acid levels during intense sports training.
Biosensors based on IQBZ technology have great potential, as it is possible to expand the portfolio of biomarkers to be tested by modifying just one technological step. It can provide a platform solution to measure multiple parameters and allow more complete monitoring of patients' health.